This inventor holds 3 USPTO granted patents and 2 EPO patents. Top assignee: Zumutor Biologics Inc.. Active years: 2018-2023.
Company Filing History:
Years Active: 2018-2023
Title: Rajeshwari Pendse: Innovator in CRISPR Technology
Introduction
Rajeshwari Pendse is a notable inventor based in Bengaluru, India. He has made significant contributions to the field of biotechnology, particularly in the area of CRISPR technology. With a total of 3 patents to his name, Pendse is recognized for his innovative approaches to modifying protein production pathways.
Latest Patents
Pendse's latest patents include groundbreaking work on the DNA-binding domain of the CRISPR system and the development of non-fucosylated and partially fucosylated proteins. His research focuses on methods for obtaining cells with modified fucosylation pathways, which leads to the production of specific antibodies. The technology employs the Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) system, targeting the Fut8 gene and GMD gene within the cells. These advancements are crucial for developing therapeutics and biomarkers, as well as for the diagnosis and prognosis of various diseases.
Career Highlights
Rajeshwari Pendse is currently associated with Zumutor Biologics Inc., where he continues to push the boundaries of biotechnological research. His work has garnered attention in the scientific community, contributing to advancements in medical science and therapeutic development.
Collaborations
Pendse collaborates with talented individuals in his field, including Aswini Thanigaivel and Sathyabalan M. These partnerships enhance the innovative potential of his research and contribute to the success of their projects.
Conclusion
Rajeshwari Pendse stands out as a pioneering inventor in the realm of CRISPR technology, with a focus on enhancing protein production for therapeutic applications. His contributions are shaping the future of biotechnology and medicine.